Russia Hopes WHO Approves Use of Sputnik V Vaksin Vaccine

Russia Hopes WHO Approves Use of Sputnik V Vaksin Vaccine

The Russian Ministry of Foreign Affairs hopes that the World Health Organization (WHO) will approve the emergency use of the Sputnik V Covid-19 vaccine in the first half of next year. Although it has been used by dozens of countries, Sputnik V has not yet obtained authorization from the WHO.

Ummatimes - Director of the Department of Economic Cooperation at the Russian Foreign Ministry, Dmitry Birichevsky, said that his party has been actively assisting the Russian Direct Investment Fund (RDIF) in marketing the Sputnik V in the international market. He said it was a routine and constant job that required the attention and cooperation of the embassy.

“We still hope that the vaccine (Sputnik V) will be requalified by WHO at some stage. I think in the first half of next year," Birichevsky said on Tuesday (7/12) quoted on the website of the Russian news agency, TASS.

According to him, only technical documents are left to give approval to Sputnik V. “This means that businesses can relax abroad knowing that our vaccines are not only approved by 71 countries. I hope to be recognized globally and then the obstacles that unfortunately exist today will be removed,” said Birichevsky.

Previously, Russian President Vladimir Putin had commented on the emergence of the Omicron variant of Covid-19. According to him, vaccination is still the only way to deal with the pandemic. Related to this, Putin highlighted that there are still different treatments for certain vaccines.

Putin called for mutual recognition of every Covid-19 vaccine. "I mean, mutual recognition of vaccines and vaccination certificates, availability of vaccines for all regions of the planet (as well as) cooperation on new drugs against the coronavirus," Putin said on November 30.

In August 2020, Russia became the first country in the world to register its developed Covid-19 vaccine, namely Sputnik V. At that time, experts expressed doubts about the vaccine's safety because Moscow had not yet conducted large-scale clinical trials.

However, the leading medical journal, The Lancet, says Sputnik has more than 90 percent efficacy. Currently at least 71 countries are already using the vaccine. So far Russia has not approved any foreign-made vaccines for use in its vaccination campaign.